Risk and Prognosis of Secondary Bladder Cancer After Radiation Therapy for Rectal Cancer: A Large Population-Based Cohort Study

被引:15
作者
Guan, Xu [1 ]
Wei, Ran [1 ]
Yang, Runkun [1 ,2 ]
Lu, Zhao [1 ]
Liu, Enrui [1 ]
Zhao, Zhixun [1 ]
Chen, Haipeng [1 ]
Yang, Ming [1 ]
Liu, Zheng [1 ]
Jiang, Zheng [1 ]
Wang, Xishan [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Colorectal Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China
关键词
rectal cancer; radiation therapy; secondary bladder cancer; prognostic factor; overall survival; cancer specific survival;
D O I
10.3389/fonc.2020.586401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Although radiation therapy (RT) improves local control for rectal cancer (RC), the long-term risks from RT, including development of a secondary malignancy, are controversial. The risk and prognosis of secondary bladder cancer (SBC) in RC patients undergoing RT have not been adequately studied. Our goal is to investigate the impact of RT on the risk of developing SBC and assess their survival outcomes. Methods This large population-based study included RC patients as their initial primary cancer from nine registries of the Surveillance, Epidemiology and End Results (SEER) database between 1973 and 2015. The cumulative incidence of SBC was assessed by using Fine and Gray's competing risk regression. The standardized incidence ratio (SIR) was used to compare the incidence of SBC in RC survivors to the US general population. The Kaplan-Meier method was used to evaluate the 10-year overall survival (OS) and 10-year cancer specific survival (CSS) for patients with SBC. Results Of 74,646 RC patients, 24,522 patients were treated with surgery and RT and 50,124 patients were treated with surgery alone. The incidence of SBC was 1.85% among patients who received RT and 1.24% among patients who did not. The incidence of SBC in RC patients who received RT was higher than the US general population (SIR, 1.35; 95% CI, 1.19-1.53, P<0.05), and decreased with increasing age at diagnosis, and increased with time since diagnosis. In competing risk regression analysis, undergoing RT was associated with a higher risk of SBC (hazard ratio [HR], 1.443, 95% confidence interval [CI], 1.209-1.720; P<0.001). The results of the dynamic SIR for SBC revealed that a slightly increased risk of SBC was observed after RT in the early latency, and was significantly related to the variations of age at RC diagnosis and decreased with time progress. The 10-year OS and CSS among SBC patients after RT were comparable to SBC patients after NRT. Conclusion Radiation was associated with an increased risk of developing SBC in RC patients, and special attention should be paid to the surveillance of these patients.
引用
收藏
页数:9
相关论文
共 17 条
[1]   Occurrence of second cancers in patients treated with radiotherapy for rectal cancer [J].
Birgisson, H ;
Påhlman, L ;
Gunnarsson, U ;
Glimelius, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :6126-6131
[2]  
Brenner DJ, 2000, CANCER, V88, P398, DOI 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO
[3]  
2-V
[4]   Risk of Second Primary Tumors in Men Diagnosed With Prostate Cancer [J].
Davis, Elizabeth J. ;
Beebe-Dimmer, Jennifer L. ;
Yee, Cecilia L. ;
Cooney, Kathleen A. .
CANCER, 2014, 120 (17) :2735-2741
[5]   Risk of Second Primary Malignancies Among Cancer Survivors in the United States, 1992 Through 2008 [J].
Donin, Nicholas ;
Filson, Christopher ;
Drakaki, Alexandra ;
Tan, Hung-Jui ;
Castillo, Alex ;
Kwan, Lorna ;
Litwin, Mark ;
Chamie, Karim .
CANCER, 2016, 122 (19) :3075-3086
[6]   Radiation-induced second cancers: The impact of 3D-CRT and IMRT [J].
Hall, EJ ;
Wuu, CS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01) :83-88
[7]   Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer [J].
Kapiteijn, E ;
Marijnen, CAM ;
Nagtegaal, ID ;
Putter, H ;
Steup, WH ;
Wiggers, T ;
Rutten, HJT ;
Pahlman, L ;
Glimelius, B ;
van Krieken, JHJM ;
Leer, JWH ;
van de Velde, CJH .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (09) :638-646
[8]   A population-based analysis of second primary cancers after irradiation for rectal cancer [J].
Kendal, Wayne S. ;
Nicholas, Garth .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (04) :333-339
[9]   Risk of second primary cancer in patients treated with radiotherapy for rectal cancer [J].
Martling, A. ;
Smedby, K. E. ;
Birgisson, H. ;
Olsson, H. ;
Granath, F. ;
Ekbom, A. ;
Glimelius, B. .
BRITISH JOURNAL OF SURGERY, 2017, 104 (03) :278-287
[10]   Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: Increased bowel dysfunction in irradiated patients - A dutch colorectal cancer group study [J].
Peeters, KCMJ ;
van de Velde, CJH ;
Leer, JWH ;
Martijn, H ;
Junggeburt, JMC ;
Kranenbarg, EK ;
Steup, WH ;
Wiggers, T ;
Rutten, HJ ;
Marijnen, CAM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :6199-6206